Introduction
Natural killer (NK) cells are large granular lymphocytes capable of spontaneously killing various tumor cells and virally infected cells. [1] [2] [3] Murine NK cells can also mediate the acute rejection of allogeneic bone marrow cells (BMCs) in lethally irradiated mice but not solid tissue allografts. [3] [4] [5] [6] [7] They also exhibit a phenomenon called "hybrid resistance" in which H2 homozygous parental BMC grafts are rejected by irradiated H2 heterozygous F 1 hybrid mice. 7 The recognition of major histocompatibility complex (MHC) class I molecules by murine NK cells is mediated by 2 families of cell surface receptors and has at least partially explained how NK cells can detect BMC allografts. 6, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] One receptor family is called Ly49, which is composed of C-lectin type II membrane glycoproteins. 6, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Individual members of these Ly49 receptors have an affinity for particular MHC class I determinants. 16, 17 Several Ly49 receptors have been identified and cDNAs have been sequenced in mice with strain-specific allelic forms being reported. [18] [19] [20] [21] Most Ly49 molecules are "inhibitory receptors," because binding to their specific targets transmits inhibitory intracellular signals through an immunoreceptor tyrosine-based inhibitory motif (ITIM) in their cytoplasmic domain. 9, 10, 16, 17 The ITIM recruits tyrosine phosphatase, which results in a potent inhibitory signal being sent to the NK cell. [15] [16] [17] Three Ly49 receptors (Ly49D, Ly49H, and Ly49P) are characterized as "activating receptors," because they lack the inhibitory motif (ITIM) in their cytoplasmic domain and instead are dependent on a noncovalently associated molecule "DAP12," which contains an immunoreceptor tyrosine-based activating motif (ITAM). 15, 22, 23 Recent studies have shown that NK cytotoxicity is regulated by a balance between expression of specific activating and inhibitory receptors. 17 A second group of MHC class I-specific receptors on NK cells is composed of disulfide bonded heterodimers termed CD94/NKG2. 16, 17 CD94 has a short cytoplasmic tail with no signaling function and it forms a heterodimer with various NKG2 proteins A, B, C, D, and E. 10, 17 We and others have shown the role of inhibitory Ly49A, C/I, and G2 NK subsets as well as the activating Ly49D NK subset in bone marrow allograft rejection in lethally irradiated mice. [22] [23] [24] [25] [26] [27] [28] [29] [30] Although a small percentage of T cells also express Ly49 receptors, mice with severe combined immunodeficiency (SCID), deficient in T and B cells, also mediate class I-specific bone marrow allograft rejection, indicating that NK cells alone can mediate the specificity seen in BMC rejection. 5 Our previous studies were designed to delineate the role of various Ly49 NK subsets in mediating BMC rejection. These studies involved infusing relatively small numbers of allogeneic BMCs that were rejected by untreated irradiated mice unless specific depletion of a Ly49 NK subset directly mediating the rejection was performed, which instead resulted in BMC engraftment. 26, 27, 29 During those studies using some Ly49 monoclonal antibodies (mAbs) as controls for examining specificity of functions of other Ly49 subsets in mediating rejection, we made a novel and unexpected preliminary observation in mice. We observed that depletion of large subsets of NK cells expressing inhibitory receptors for a given H2 type of BMC had 2 effects: (1) increased resistance to the H2 type BMCs that these receptors recognized to receive negative signals and (2) weakening of rejection against BMC grafts that were not recognized by the particular NK receptor. For example, depletion of Ly49G2 ϩ NK cells, which receive negative signals from H2 d but not H2 b class I antigens, led to decreased ability of H2 d host mice to reject H2 b BMCs. 27 We describe here in more detail the in vivo effect of depletion of Ly49 NK subsets, which do not directly mediate the rejection of H2 d or H2 b haplotype BMCs, on the rejection of higher numbers of BMCs and discuss the potential relevance of these findings in clinical bone marrow transplantation (BMT).
Materials and methods

Mice
BALB/c (H2 d ), C.B-17 SCID (H2 d ), C57BL/6 (H2 b ), and BALB/c ϫ C57BL/6 F 1 (CB6F 1 , H2 bxd ), mice were obtained from the Animal Production Area, National Cancer Institute (Frederick, MD). All mice were kept under specific pathogen-free conditions until use at 8 to 12 weeks of age.
NK cell isolation and flow cytometric analysis
Groups of 5 to 10 C57BL/6 (H2 b ) mice were injected intraperitoneally with 500 g mAb 5E6 (anti-Ly49C/I) or 200 g mAb 4D11 (anti-Ly49G2) or 0.2 mL normal rat serum (NRS). Seventy-two hours later spleens were harvested and single-cell suspensions were prepared. Four-color flow cytometric analysis was performed to determine the percentage of Ly49C/ I ϩ , Ly49G2 ϩ , and Ly49D ϩ NK cells. Cells were incubated with phycoerythrin (PE)-conjugated mAbs 5E6 (anti-Ly49C/I) or 4E5 (anti-Ly49D), fluorescein isothiocyanate (FITC)-conjugated mAb 4D11 (anti-Ly49G2) or goat-antimouse/rat IgG, allophycocyanin (APC)-conjugated NK pan marker NK1.1 and peridinin chlorophyll protein (PCP)-conjugated anti-CD3 for 30 minutes at 4°C. After 2 washes, the cells were analyzed on an LSR flow cytometer (Becton Dickinson, San Jose, CA). All secondary antibodies were titered and tested for their ability to stain for primary antibodies.
Assays for BMC engraftment
Groups of 4 to 5 conventionally housed recipient mice were injected intraperitoneally with 500 g mAb 5E6 (anti-Ly49C/I), 200 g mAb 4D11 (anti-Ly49G2), 500 g of mAb PK136 (anti-NK 1.1), 20 L antiasialo GM1 (anti-ASGM1; Wako Chemicals, Richmond, VA), 0.2 mL NRS, or 120 g polyinosinic/ polycytidylic (poly I:C), 2 days before irradiation. The engraftment of donor BMCs was assessed by an in vitro colony assay for hematopoietic cell growth. 26 Two days after antibody injection, mice were lethally irradiated with a 137 Cs source (BALB/c at 850 cGy, C57BL/6 at 950 cGy, C.B-17 SCID at 350 cGy, and CB6F 1 at 1000 cGy) and later injected intravenously with 0.5 ϫ 10 6 to 25 ϫ 10 6 BMCs in 0.5 mL phosphate-buffered saline (PBS). At day 8, spleens were gently crushed in medium and single-cell suspensions were prepared. Then, 10 6 spleen cells were plated in 0.3% sea plaque agar in 35-mm dishes containing optimal concentrations of recombinant murine cytokines (interleukin 3 [IL-3; 10 ng/mL] and granulocyte-macrophage colony-stimulating factor [GM-CSF; 10 ng/mL]). Cytokines were obtained from the Biological Resources Branch (Frederick, MD). Plates were incubated at 37°C for 7 days and the colonies with more than 50 cells were counted (colony-forming unit-culture [CFU-c]). The data are presented as mean Ϯ SD total CFU-c per spleen, which was obtained by multiplying number of colonies by the cellularity. The Student t test was performed to determine if the mean values were significantly different (P Ͻ .05). Each experiment was performed 3 to 4 times with at least 4 mice per group.
Results
We have reported earlier that in BALB/c (H2 d ) mice, the Ly49G2 ϩ NK subset can mediate the rejection of allogeneic H2 b BMCs and conversely Ly49C/I ϩ NK cells are responsible for the rejection of H2 d BMCs in C57BL/6 (H2 b ) mice as ascertained by the in vivo depletion of these subsets. 25, 26, 29 While studying the in vivo role of Ly49G2 ϩ NK subset in BALB/c (H2 d ) mice, we observed an interesting phenomenon by using antibodies directed against the Ly49C/I ϩ NK cell subset as control for the specificity of Ly49G2 ϩ NK subset removal. 26 Depletion of Ly49C/I ϩ NK cells in BALB/c (H2 d ) mice, which is the NK subset that receives negative signals from H2K b and therefore cannot reject H2 b BMCs, resulted in the ability of the recipient mice to reject higher numbers of allogeneic H2 b BMCs. 26 Therefore, depletion of a population of NK cells that were considered indifferent to H2 b BMCs nevertheless resulted in enhanced rejection by H2 d mice.
We carried out further transplantation studies to determine the effects of in vivo depletion of this and other Ly49 NK subsets that are not responsible for the rejection of a particular BMC allograft. To do this, we wanted to assess the effect of NK subset removal in instances where increasing BMC numbers could overcome resistance and result in engraftment. The number of allogeneic BMCs transplanted varied because mice differ in their BMC rejection capability. We examined the effect of in vivo depletion of Ly49C/I ϩ or G2 ϩ NK subsets on allograft rejection in BALB/c (H2 d ) mice. Mice were injected with 200 g mAb 4D11 (anti-Ly49G2) or 500 g mAb 5E6 (anti-Ly49C/I) to deplete the respective Ly49 NK subset and 48 hours later mice were lethally irradiated and allogeneic BMCs were infused. After 8 days, the splenic CFU-c assay, which quantitates hematopoietic progenitors as reflected by growth in agar, was performed to assess BMC engraftment in mice. The CFU-c assay was chosen over the ( 125 I) UdR radioisotope incorporation assay because though both assays detect progenitor cell function, the CFU-c assay, in addition, detects the production of CFU-c precursor/progenitor cells derived from the inoculum, whereas the other detects any proliferating marrow-derived cells in S-phase of the cycle. The results presented in Figure 1A demonstrate that irradiated BALB/c mice were capable of resisting 0.5 ϫ 10 6 H2 b BMCs, whereas the syngeneic control H2 b C57BL/6 mice engrafted H2 b BMCs. When the total NK cell population was removed by injecting ASGM1 antibodies, engraftment of allogeneic H2 b BMCs was enhanced (P Ͻ .0001; Figure 1A ). Removal of Ly49C/I ϩ NK subset, which does not mediate the rejection of allogeneic H2 b BMCs as they receive negative signals from H2K b BMCs, led to rejection of the BMCs but depletion of Ly49G2 ϩ NK cells (which receive negative signals from H2D d BMCs and therefore can mediate the rejection of H2 b BMCs) significantly increased the engraftment of allogeneic H2 b BMCs compared with the control group (NRS treated). 26 However, when rejection was overridden by infusing larger numbers of (8 ϫ Next, we performed the reciprocal experiment. We examined the effect of depletion of the Ly49C/I ϩ or Ly49G2 ϩ NK subset on the rejection of higher numbers of allogeneic H2 d BMCs in irradiated C57BL/6(H2 b ) mice to assess whether Ly49G2 ϩ NK cells were able to inhibit the ability of mice to reject H2 d BMCs. 23, 24 In lethally irradiated H2 b mice, the Ly49C/I ϩ NK subset has been shown to mediate the rejection of allogeneic H2 d BMCs when transplanted in limited (0.5 ϫ 10 6 ) numbers (Figure 2A) . 25, 29 However, when allogeneic H2 d BMCs were infused in larger numbers (25 ϫ 10 6 BMCs), the control group (NRS treated) could no longer reject the bone marrow allograft because the CFU-c content was similar to mice depleted of all NK cells by NK1.1 mAb and syngeneic control ( Figure 2B-C) . Under such circumstances, Figure 2 . Effect of depletion of Ly49G2 ؉ or Ly49C/I ؉ NK subsets in H2 b C57BL/6 mice on the engraftment of H2 d allografts. Mice were given various mAb treatments or NRS 2 days before irradiation. Irradiated mice (4 mice/group) received 0.5 ϫ 10 6 (A) or 25 ϫ 10 6 (B,C) allogeneic BMCs. On the eighth day a soft agar colony assay was done to assess hematopoietic progenitor content in the spleens (mean Ϯ SD). *Values significantly (P Ͻ .0001) greater than mice receiving NRS in experiment A; **values significantly (P Ͻ .0001) greater than mice receiving NRS in experiment A; ***values significantly (P Ͻ .006) lower than mice receiving NRS in experiment B; ****values significantly (P Ͻ .003) lower than mice receiving NRS in experiment C; *****values significantly (P Ͻ .001) greater than mice receiving anti-Ly49G2 (mAb 4D11) only in experiment C. Mice were given various mAb treatments or NRS 2 days before irradiation. Irradiated mice (4 mice/group) received 0.5 ϫ 10 6 (A) or 8 ϫ 10 6 (B,C) allogeneic BMCs. On the eighth day a soft agar colony assay was done to assess hematopoietic progenitor content in the spleens (mean Ϯ SD). *Values significantly (P Ͻ .0001) greater than mice receiving NRS in experiment A; **values significantly (P Ͻ .0001) greater than mice receiving NRS in experiment A; ***values significantly (P Ͻ .0001) lower than mice receiving NRS in experiment B; ****values significantly (P Ͻ .0001) lower than mice receiving NRS in experiment C; *****values significantly (P Ͻ .002) greater than mice receiving anti-Ly49C/I (mAb 5E6) in experiment C.
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RAZIUDDIN NK cells in F 1 (H2 bxd ) hybrid mice can reject both parental bone marrow allografts when transplanted in limited numbers, by a phenomenon called "hybrid resistance." 7 In F 1 (H2 bxd ) mice, Ly49C/I and G2 receptors are also exposed to their "self-ligands" H2 b and H2 d , respectively, in vivo, which transmit inhibitory signals to NK cells. Therefore, it was of interest to examine the effect of depletion of Ly49 NK subsets in a hybrid resistance model, that is, depleting the NK subset that does not mediate the rejection of a particular haplotype BMC (Ly49C/I for H2 b and Ly49G2 for H2 d BMCs) on the rejection of higher numbers of those parental BMCs in F 1 (H2 bxd ) mice.
We have reported earlier, and also show in Figure 3A , that in CB6F 1 (H2 bxd ) hybrid mice NK cells expressing inhibitory Ly49G2 receptors mediate the rejection of parental H2 b BMCs (0.5 ϫ 10 6 ) because depletion of the Ly49G2 ϩ NK subset in vivo results in the engraftment of the BMCs. 26 However, when higher numbers of H2 b BMCs (20 ϫ 10 6 ) were transplanted to override the resistance, removal of Ly49G2 ϩ NK cells (which plays a role in mediating the rejection of H2 b BMCs in heterozygous F 1 [H2 bxd ] and homozygous H2 d mice) did not augment allograft engraftment when compared to the control group (NRS-treated group; Figure 3B ). Interestingly, similar to the results in homozygous H2 d mice ( Figure 1B ), significant rejection of parental H2 b bone marrow allografts occurred (P Ͻ .006) in Ly49C/I ϩ NK subset-depleted group when compared with anti-NK1.1-treated group, where all NK cells were depleted.
Weak resistance to parental BALB/c(H2 d ) bone marrow allografts has been reported to occur by F 1 (H2 bxd ) hybrid mice and this rejection can be enhanced by using BMCs that are depleted of T cells. 31 We have used C.B-17 SCID (H2 d ) BMCs as donors because it has been shown that the rejection pattern of congenitally T cell-deficient C.B-17 SCID BMCs is identical to BALB/c BMCs that were depleted of T cells. 31 The BMT results presented in Figure 4A demonstrate that as reported earlier, in CB6F 1 (H2 bxd ) hybrid mice, NK cells expressing inhibitory Ly49C/I receptors mediate the rejection of parental H2 d BMCs (0.5 ϫ 10 6 ) as depletion of Ly49C/I ϩ subset in vivo results in the engraftment of the C.B-17 SCID (H2 d ) BMCs. 26 Removal of the other Ly49 NK subset, that is, the Ly49G2 NK subset that does not mediate the rejection of H2 d BMCs instead resulted in the rejection of the bone marrow allograft, similar to the control group, whereas syngeneic controls engrafted the BMCs ( Figure 4A) . Increasing the C.B-17 SCID (H2 d ) BMCs to 4 ϫ 10 6 also resulted in rejection by the host ( Figure 4B ). However, when parental 4 ϫ 10 6 BALB/c (H2 d ) BMCs were transplanted there was engraftment of H2 d BMCs in the control group (NRS treated) and the reason is weak resistance to parental BALB/c (H2 d ) bone marrow allografts by F 1 (H2 bxd ) hybrid mice. 31 Removal of Ly49C/I ϩ NK cells (H2 d rejecting) did not augment allograft engraftment when compared with the control group (NRS-treated group; Figure 4C ). Interestingly, as observed in homozygous H2 b mice ( Figure 2B-C) , removal of Ly49G2 ϩ NK cells, which does not mediate the rejection of H2 d BMCs, resulted in enhanced rejection of H2 d bone marrow allografts (P Ͻ .02) by the irradiated F 1 recipients ( Figure 4C) .
Hence, the ability of F 1 (H2 bxd ) hybrid mice to reject larger numbers of either parental BMCs (H2 d or H2 b ) is enhanced on the depletion of a specific Ly49 NK subset, Ly49G2 ϩ and Ly49C/I ϩ , respectively.
Augmentation of the ability of C.B-17 SCID (H2 d ) mice to reject H2 b BMCs following depletion of Ly49C/I ؉ NK subset
To ascertain whether enhanced rejection of allogeneic BMCs is indeed due to NK cells versus NK/T or T cells, we performed the BMT experiment in C.B-17 SCID (H2 d ) mice, which are deficient in T and B cells. 5 Results presented in Figure 5 demonstrate that depletion of Ly49C/I ϩ NK subset in C.B-17 SCID (H2 d ) mice enhanced their ability to reject large numbers of allogeneic H2 b BMCs when compared with the control group treated with NRS (P Ͻ .0001). This is consistent with results also observed in BALB/c (H2 d ) mice ( Figure 1B) . Removal of Ly49G2 ϩ NK cells We wondered whether the enhanced allograft resistance in the NK subset-depleted mice might be due to an expansion of the Ly49 NK subset, capable of mediating rejection after depletion of the nonrejecting subset. C57BL/6 (H2 b ) mice were injected with 200 g anti-Ly49G2 (4D11 mAb) or 500 g anti-Ly49C/I (5E6 mAb) and 48 hours later half the mice were lethally irradiated. Seventytwo hours after mAb treatment (24 hours after irradiation) spleen cells were stained from nonirradiated and irradiated mice with various Ly49 fluoresceinated mAbs. Staining with a goat-antimouse antibody (to detect mAb 5E6 bound to NK cells in mAb 5E6-treated mice) or goat-anti-rat antibody (to detect mAb 4D11 bound to NK cells in mAb 4D11-treated mice) was completely negative, suggesting that antibody treatment resulted in depletion of the subsets ( Figure 6A ). Results presented in Figure 6B and 6C, demonstrate that in vivo treatment of C57BL/6 mice with the mAb 4D11 (anti-Ly49G2) or mAb 5E6 (anti-Ly49C/I) depleted 90% or more of splenic Ly49G2 ϩ and Ly49C/I ϩ NK cells, respectively. However, no increase in absolute numbers of splenic Ly49C/I ϩ NK cells was detected in Ly49G2 NK subset-depleted C57BL/6 (H2 b ) mice and vice versa. A slight decrease in the total Ly49C/I ϩ NK cell numbers was noted, most likely due to removal of double-positive Ly49C/I ϩ G2 ϩ cells. Therefore, these data suggest that no compensatory expansion of surviving subsets occurred, at least within the time frame of 3 days.
Interestingly, in C57BL/6 (H2 b ) mice in which the Ly49G2 NK subset was removed by mAb 4D11, (Figure 6B ,C) a significant increase in the percentage of Ly49C/I ϩ (P Ͻ .0001) and Ly49D ϩ NK cells (P Ͻ .0001) was noted (control, 25.9% Ϯ 2.4% Ly49C/I ϩ and 19.8% Ϯ 1.0% Ly49D ϩ cells; mAb 4D11 treated, 51.1% Ϯ 2.3% Ly49C/I ϩ and 47.8% Ϯ 2.8% Ly49D ϩ cells). Therefore, enhanced rejection of H2 d BMCs observed in Ly49G2 subset-depleted C57BL/6 (H2 b ) mice ( Figure 2B -C) may be due at least in part to an increased likelihood of allogeneic BMCs coming in contact with NK cells responsible for rejection.
In agreement with these data, mice receiving the mAb 5E6 (anti-Ly49C/I) also had a significant increase in the percentage of Ly49G2 ϩ NK cells ( Figure 6B-C) , which correlated with the increased ability of H2 d mice to reject H2 b BMC allograft after Ly49C/I ϩ NK subset depletion ( Figure 1B-C) . The activating receptor for H2 b BMC grafts has not been identified but Ly49H is a candidate because it is similar to Ly49C and Ly49I in the extracellular domain. 32 Next, we did the flow cytometric analysis of Ly49 NK subsets 72 hours following depletion in the spleen cells of lethally irradiated mice. The results presented in Figure 7 indicate that the percentage of NK cells following irradiation increased in the untreated (nonirradiated, 3.3%; irradiated, 23.4%) as well as On the eighth day a soft agar colony assay was done to assess hematopoietic progenitor content in the spleens (mean Ϯ SD). *Values significantly (P Ͻ .001) greater than mice receiving NRS in experiment A; **values significantly (P Ͻ .0002) greater than mice receiving NRS in experiment A; ***values significantly (P Ͻ .0001) lower than mice receiving NK1.1 in experiment B; ****values significantly (P Ͻ .02) lower than mice receiving NRS in experiment C.
Ly49C/I NK subset-depleted (nonirradiated, 1.4%; irradiated, 6.9%) or Ly49G2 NK subset-depleted group (nonirradiated, 2.6%; irradiated, 15.5%) because of killing of radiosensitive cells by irradiation and removal of NK subsets by Ly49 antibody treatments ( Figure 7A) . However, the total number of NK cells also decreased in the untreated control group following irradiation (nonirradiated, 2.09 ϫ 10 6 ; irradiated, 0.86 ϫ 10 6 ) and even further in mAbtreated groups ( Figure 7B ).
Similar to the effects observed in nonirradiated C57BL/6 (H2 b ) mice (Figure 6 ), in lethally irradiated C57BL/6 (H2 b ) mice, Ly49G2 NK subset removal by mAb 4D11 led to a significant increase in the percentage of Ly49C/I ϩ cells, whereas the Ly49C/I NK subset removal by 5E6 mAb treatment led to a significant increase in the percentage of Ly49G2 ϩ NK cells ( Figure 8A-B) . These results indicate that antibody depletion of the subsets was not altered when irradiation was performed.
Discussion
We have previously described the roles of various Ly49 NK subsets (inhibitory and activating) in bone marrow allograft rejection in lethally irradiated mice. 26, 27, 29 However, all previous studies involved transplanting limiting numbers of allogeneic BMCs, which were rejected by the control (untreated) irradiated mice. During those studies, we observed that in H2 d mice, removal of the inhibitory Ly49C/I NK subset, which played no role in the rejection of allogeneic H2 b grafts, augmented rejection of larger numbers of H2 b BMCs. 26 This suggested that such NK subsets are potentially "immunoregulatory" and may functionally regulate the NK cells that mediate marrow graft rejection.
Our previous studies examined the ability of Ly49 NK subset removal to abrogate bone marrow allograft rejection and the work It is possible that the enhanced rejection observed by removal of either Ly49G2 ϩ or C/I ϩ NK cells is due to either the expansion in cell numbers or the enrichment of the NK subset directly mediating the rejection. Depletion of the Ly49G2 ϩ NK subset, in H2 b mice (Figures 6 and 7) or the Ly49C/I ϩ NK subset, in H2 d mice (data not shown) did not result in expansion of cell numbers of the other NK subset but did result in enrichment of Ly49C/I ϩ and Ly49D ϩ NK cells (Figures 6 and 8) It is well documented that BMC rejection in mice can be enhanced by treatment with poly I:C in vivo. 33, 34 Poly I:C treatment activates the macrophages, which produce IFN-␣/␤, and that enhances NK cell cytotoxicity. 33, 34 Interestingly, removal of the appropriate Ly49 NK subset enhances the BMC rejection capability of the remaining NK1.1 ϩ cells significantly greater than poly I:C-activated cells. NK cells also produce a variety of cytokines on activation, for example, GM-CSF, IFN-␥, tumor necrosis factor ␣, transforming growth factor ␤, and so forth. 35 Therefore, one mechanism may be novel NK-NK cell immunoregulation whereby one Ly49 NK subset influences another Ly49 NK subset(s) mediating rejection possibly through the production of cytokines or other factors. Removal of that subset relieves the inhibition of NK cells mediating the rejection and results in enhanced rejection of allogeneic BMCs. These studies suggest that caution must be exercised when using other Ly49 mAbs because negative controls in in vivo assays examining the role or function of a particular NK subset because activity of the remaining subsets may be heightened.
We have previously observed that in H2 d mice, Ly49C/I ϩ NK cells produce larger amounts of the growth-promoting cytokine (GM-CSF) than the growth inhibiting cytokine (IFN-␥). 36 Similarly, in H2 b mice, Ly49G2 ϩ NK cells produce larger amounts of the growth-promoting cytokine (GM-CSF) than growth inhibiting cytokine (IFN-␥; unpublished data, January 1994). Therefore, depletion of Ly49C/I ϩ or Ly49G2 ϩ NK cells in a particular Forty-eight hours later, 5 mice from each group were lethally irradiated at 950 cGy and 24 hours after irradiation (total 72 hours since antibody treatments) spleens from all the mice were harvested, each group of spleens pooled, and single-cell suspension prepared. Four-color flow cytometric analysis was performed as mentioned in "Materials and methods." The figure represents NK percentage (A) and total NK cell numbers (B) in the spleens of nonirradiated and irradiated mice.
